Drug price drops in 2026 largely stem from prior administration's legislation, experts say

Brand-name drug list prices have fallen sharply in 2026, but analysts and policy experts attribute most of the decline to a law enacted under the previous administration, not to recent executive actions. The White House has claimed credit for the reductions, yet the evidence points to the earlier legislation as the primary driver.